Supply of pembrolizumab under drug programme B.6, Institute of Tuberculosis and Lung Diseases
Open · 27 days left Poland · Medicines
| Buyer | Instytut Gruzlicy i Chorob Pluc (National Institute of Tuberculosis and Lung Diseases), Warsaw |
|---|---|
| Reference | AP.26.101.2026 |
| Closing date | 15 December 2026 |
| Products | Pembrolizumab reimbursed under the National Health Fund drug programme B.6 (lung cancer). Open tender published 12 Nov 2026. |
PharmaTradz is not the buyer. Read the full tender documents and any addenda on the buyer's site before bidding; they always prevail over this summary.
Typical documents for a medicines tender
- Registration in the buyer's country, or the alternative the tender accepts (for example WHO prequalification)
- GMP certificate for the manufacturing site and a certificate of pharmaceutical product (CoPP)
- Certificates of analysis, samples, stability data and labelling in the required language
- Bid security, authorisation letters and price schedules in the buyer's format
Need a supplier for this tender?
Tell us the lots, strengths and quantities. We match registered, GMP-certified manufacturers and can help with tender documents.
Request supplier quotesNew tenders in Poland
We email you when new tenders for this country are listed. Confirm first; unsubscribe any time.
Other open tenders
- Medicines in 5 ATC packages, Boleslawiec regional psychiatric hospital (Poland, 27 Nov)
- Backup supply of injectable medicines if CENABAST cannot deliver, Hospital del Salvador (Chile, 23 Nov)
- Carfilzomib 60 mg for the SUS oncology programme, Ministry of Health (Brazil, 26 Nov)
- Framework agreement for oral anticancer medicines for Hospital Clinico San Carlos, Madrid (Spain, 27 Nov)
- Framework for unlicensed imported medicines (wave 2), North East and Yorkshire NHS (United Kingdom, 30 Nov)
- Central purchase of fluorouracil 1000 mg/20 ml injection, CENABAST (Chile, 3 Dec)